Krishna Rocha-Singh, M.D., FACC
Chief Medical Advisor
Dr. Krishna Rocha-Singh is chief scientific officer for Prairie Heart Institute at St. John’s Hospital in Springfield, Ill. In addition, he is a current co-founding board member of Vascular InterVentional Advances (VIVA), a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research. In his role as VIVA’s research director, he has collaborated with the Food and Drug Administration (FDA) in developing several objective performance criteria, which are currently being used by the industry for clinical trials of nitinol stents in symptomatic peripheral arterial disease and resistant hypertension secondary to atherosclerotic renovascular disease. Dr. Rocha-Singh has served as a board or committee member on numerous medical societies including the American College of Cardiology, American Board of Vascular Medicine and Society of Cardiovascular Angiography and Intervention and is presently on several academic journal editorial boards. Dr. Rocha-Singh has authored over 100 books, book chapters and peer-reviewed manuscripts on coronary and peripheral endovascular interventional subjects. A board-certified cardiologist, he holds a medical degree from the University of California, Los Angeles; completed residency at University of Colorado, Denver; and Cardiology Fellowship at the University of California, San Francisco, California & Scripps Clinic & Research Foundation, La Jolla.